Figure 2.
Types of organoids used in oncology. In cancer research, organoids either derived from healthy tissues (green box) or from cancer specimens (red box) can be employed. While, healthy organoids may be genetically modified and used to study cancer genesis and development (green box), Patients Derived Tumor Organoids (PDTOs) are valid tools to study metastasization and for translational oncology applications (red box).
